Endothelin-1 Is Involved in Norepinephrine-Induced Ventricular Hypertrophy In Vivo
- 1 June 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 93 (11), 2068-2079
- https://doi.org/10.1161/01.cir.93.11.2068
Abstract
Background Endothelin-1 (ET-1) has potent effects on cell growth and induces hypertrophy of cultured ventricular myocytes. Catecholamines increase expression of ET-1 mRNA by cultured myocytes. We investigated the role of endogenous ET-1 in catecholamine-induced hypertrophy in vivo by studying the effects of continuous norepinephrine infusion on physical and molecular markers of ventricular hypertrophy, ventricular and noncardiac expression of ET-1 mRNA, and the acute effects of bosentan, an orally active ET A and ET B receptor antagonist. Methods and Results Seventy male Sprague-Dawley rats (175 to 200 g) were divided into four groups: (1) sham-operated rats, (2) norepinephrine-infused rats (600 μg·kg −1 ·h −1 by subcutaneous osmotic pump, up to 7 days), (3) sham-operated rats given bosentan, and (4) norepinephrine-infused rats given bosentan. Bosentan (100 mg/kg once daily) was administered by gavage for 6 days starting 1 day before operation. Norepinephrine caused increases in absolute ventricular weight and ratios of ventricular weight to body weight and ventricular RNA to protein. Ventricular expression of mRNAs for atrial natriuretic factor, skeletal α-actin, and β-myosin heavy chain, which in adult rat ventricle are indicators of hypertrophy, also increased. Ventricular expression of ET-1 mRNA was elevated in the norepinephrine group at 1, 2, and 3 days. By 5 days, this had fallen to control levels. In lung, kidney, and skeletal muscle, norepinephrine did not significantly increase expression of ET-1 mRNA. Bosentan attenuated norepinephrine-induced increases in ventricular weight, ratio of RNA to protein, and expression of skeletal α-actin mRNA and β-myosin heavy chain mRNA at 5 days, but it did not attenuate increased ventricular expression of atrial natriuretic factor mRNA. Conclusions These data suggest that endogenous ET-1 plays a direct role in mediating norepinephrine-induced ventricular hypertrophy in vivo.Keywords
This publication has 41 references indexed in Scilit:
- Stimulation of adult rat ventricular myocyte protein synthesis and phosphoinositide hydrolysis by the endothelinsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Two Subtypes of the Endothelin Receptor (ETA and ETB) Mediate Vasoconstriction in the Perfused Rat HeartJournal of Cardiovascular Pharmacology, 1993
- cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNABiochemical and Biophysical Research Communications, 1991
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990
- The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes.Journal of Clinical Investigation, 1990
- Inhibition of the release of arachidonic acid prevents the development of sarcolemmal membrane defects in cultured rat myocardial cells during adenosine triphosphate depletion.Journal of Clinical Investigation, 1988
- The elucidation of the structure of atrial natriuretic factor, a new peptide hormoneCanadian Journal of Physiology and Pharmacology, 1987
- Ventricular atriopeptin. Unmasking of messenger RNA and peptide synthesis by hypertrophy or dexamethasone.Hypertension, 1987
- Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathwaysCell, 1986